Patents by Inventor Anand G. Patel

Anand G. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and materials for assessing responsiveness to PARP inhibitors and platinating agents
    Patent number: 8729048
    Abstract: This document provides methods and materials involved in assessing responsiveness to PARP inhibitors and platinating agents. For example, methods and materials for using levels of non-homologous end-joining pathway members (e.g., artemis mRNA or polypeptide levels, Ku80 mRNA or polypeptide levels, or DNA-PKcs mRNA or polypeptide levels) to determine if cancer cells that are homologous recombination-deficient are likely to be susceptible or resistant to PARP inhibitors and platinating agents are provided.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: May 20, 2014
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Scott H. Kaufmann, Anand G. Patel
  • Methods and materials for assessing enzyme-nucleic acid complexes
    Patent number: 8530172
    Abstract: This document relates to methods and materials involved in assessing samples for enzyme-nucleic acid complexes. For example, methods and materials for using antibodies to determine the presence, absence, or amount of enzyme-nucleic acid complexes (e.g., human topoisomerase I-DNA complexes) in a sample (e.g., a biological sample such as a tissue biopsy) are provided.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: September 10, 2013
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Scott H. Kaufmann, Anand G. Patel
  • METHODS AND MATERIALS FOR ASSESSING ENZYME-NUCLEIC ACID COMPLEXES
    Publication number: 20110287441
    Abstract: This document relates to methods and materials involved in assessing samples for enzyme-nucleic acid complexes. For example, methods and materials for using antibodies to determine the presence, absence, or amount of enzyme-nucleic acid complexes (e.g., human topoisomerase I-DNA complexes) in a sample (e.g., a biological sample such as a tissue biopsy) are provided.
    Type: Application
    Filed: May 19, 2011
    Publication date: November 24, 2011
    Inventors: Scott H. Kaufmann, Anand G. Patel